Medical Care

Global Exogenous Circular RNA Synthesis Service Market Research Report 2025

The global market for Exogenous Circular RNA Synthesis Service was valued at US$ 2069 million in the year 2024 and is projected to reach a revised size of US$ 4393 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Circular RNA (circRNA) is a class of non-coding RNA molecules with a closed loop structure, lacking the 5′ cap and 3′ poly(A) tail structures (as shown in Figure 1). CircRNAs are primarily located in the cytoplasm or stored in exosomes, where they are resistant to RNA exonuclease degradation, making them more stable and less prone to degradation. CircRNAs have been shown to be widely present in various eukaryotic organisms. Most circRNAs are formed by the circularization of exons, while some are formed by the circularization of introns into lariat structures. Additionally, circRNAs contain abundant miRNA response elements (MREs), which can interact with AGO proteins to form the catalytic core of the RNA-induced silencing complex (RISC), ultimately leading to circRNA degradation.
North American market for Exogenous Circular RNA Synthesis Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Exogenous Circular RNA Synthesis Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Exogenous Circular RNA Synthesis Service in Drug Discovery is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Exogenous Circular RNA Synthesis Service include GenScript, Guangzhou IGE Biotechnology, Geneseed, Azenta Life Sciences, Beyotime, VectorBuilder, Yaohai Biological, Creative Biogene, GeneCopoeia, CircNova, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Exogenous Circular RNA Synthesis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exogenous Circular RNA Synthesis Service.
The Exogenous Circular RNA Synthesis Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Exogenous Circular RNA Synthesis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Exogenous Circular RNA Synthesis Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GenScript
Guangzhou IGE Biotechnology
Geneseed
Azenta Life Sciences
Beyotime
VectorBuilder
Yaohai Biological
Creative Biogene
GeneCopoeia
CircNova
Creative Biolabs
Bio-Synthesis
Hongene Biotech
Segment by Type
Chemical Synthesis Method
Ligase Method
Ribozyme Method
Segment by Application
Drug Discovery
Cell Therapy
Vaccine R&D
Disease Mechanism
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exogenous Circular RNA Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exogenous Circular RNA Synthesis Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemical Synthesis Method
1.2.3 Ligase Method
1.2.4 Ribozyme Method
1.3 Market by Application
1.3.1 Global Exogenous Circular RNA Synthesis Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Cell Therapy
1.3.4 Vaccine R&D
1.3.5 Disease Mechanism
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exogenous Circular RNA Synthesis Service Market Perspective (2020-2031)
2.2 Global Exogenous Circular RNA Synthesis Service Growth Trends by Region
2.2.1 Global Exogenous Circular RNA Synthesis Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Exogenous Circular RNA Synthesis Service Historic Market Size by Region (2020-2025)
2.2.3 Exogenous Circular RNA Synthesis Service Forecasted Market Size by Region (2026-2031)
2.3 Exogenous Circular RNA Synthesis Service Market Dynamics
2.3.1 Exogenous Circular RNA Synthesis Service Industry Trends
2.3.2 Exogenous Circular RNA Synthesis Service Market Drivers
2.3.3 Exogenous Circular RNA Synthesis Service Market Challenges
2.3.4 Exogenous Circular RNA Synthesis Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Exogenous Circular RNA Synthesis Service Players by Revenue
3.1.1 Global Top Exogenous Circular RNA Synthesis Service Players by Revenue (2020-2025)
3.1.2 Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Exogenous Circular RNA Synthesis Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Exogenous Circular RNA Synthesis Service Revenue
3.4 Global Exogenous Circular RNA Synthesis Service Market Concentration Ratio
3.4.1 Global Exogenous Circular RNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exogenous Circular RNA Synthesis Service Revenue in 2024
3.5 Global Key Players of Exogenous Circular RNA Synthesis Service Head office and Area Served
3.6 Global Key Players of Exogenous Circular RNA Synthesis Service, Product and Application
3.7 Global Key Players of Exogenous Circular RNA Synthesis Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exogenous Circular RNA Synthesis Service Breakdown Data by Type
4.1 Global Exogenous Circular RNA Synthesis Service Historic Market Size by Type (2020-2025)
4.2 Global Exogenous Circular RNA Synthesis Service Forecasted Market Size by Type (2026-2031)
5 Exogenous Circular RNA Synthesis Service Breakdown Data by Application
5.1 Global Exogenous Circular RNA Synthesis Service Historic Market Size by Application (2020-2025)
5.2 Global Exogenous Circular RNA Synthesis Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Exogenous Circular RNA Synthesis Service Market Size (2020-2031)
6.2 North America Exogenous Circular RNA Synthesis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Exogenous Circular RNA Synthesis Service Market Size by Country (2020-2025)
6.4 North America Exogenous Circular RNA Synthesis Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Exogenous Circular RNA Synthesis Service Market Size (2020-2031)
7.2 Europe Exogenous Circular RNA Synthesis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Exogenous Circular RNA Synthesis Service Market Size by Country (2020-2025)
7.4 Europe Exogenous Circular RNA Synthesis Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size (2020-2031)
8.2 Asia-Pacific Exogenous Circular RNA Synthesis Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Exogenous Circular RNA Synthesis Service Market Size (2020-2031)
9.2 Latin America Exogenous Circular RNA Synthesis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Exogenous Circular RNA Synthesis Service Market Size by Country (2020-2025)
9.4 Latin America Exogenous Circular RNA Synthesis Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size (2020-2031)
10.2 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GenScript
11.1.1 GenScript Company Details
11.1.2 GenScript Business Overview
11.1.3 GenScript Exogenous Circular RNA Synthesis Service Introduction
11.1.4 GenScript Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.1.5 GenScript Recent Development
11.2 Guangzhou IGE Biotechnology
11.2.1 Guangzhou IGE Biotechnology Company Details
11.2.2 Guangzhou IGE Biotechnology Business Overview
11.2.3 Guangzhou IGE Biotechnology Exogenous Circular RNA Synthesis Service Introduction
11.2.4 Guangzhou IGE Biotechnology Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.2.5 Guangzhou IGE Biotechnology Recent Development
11.3 Geneseed
11.3.1 Geneseed Company Details
11.3.2 Geneseed Business Overview
11.3.3 Geneseed Exogenous Circular RNA Synthesis Service Introduction
11.3.4 Geneseed Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.3.5 Geneseed Recent Development
11.4 Azenta Life Sciences
11.4.1 Azenta Life Sciences Company Details
11.4.2 Azenta Life Sciences Business Overview
11.4.3 Azenta Life Sciences Exogenous Circular RNA Synthesis Service Introduction
11.4.4 Azenta Life Sciences Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.4.5 Azenta Life Sciences Recent Development
11.5 Beyotime
11.5.1 Beyotime Company Details
11.5.2 Beyotime Business Overview
11.5.3 Beyotime Exogenous Circular RNA Synthesis Service Introduction
11.5.4 Beyotime Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.5.5 Beyotime Recent Development
11.6 VectorBuilder
11.6.1 VectorBuilder Company Details
11.6.2 VectorBuilder Business Overview
11.6.3 VectorBuilder Exogenous Circular RNA Synthesis Service Introduction
11.6.4 VectorBuilder Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.6.5 VectorBuilder Recent Development
11.7 Yaohai Biological
11.7.1 Yaohai Biological Company Details
11.7.2 Yaohai Biological Business Overview
11.7.3 Yaohai Biological Exogenous Circular RNA Synthesis Service Introduction
11.7.4 Yaohai Biological Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.7.5 Yaohai Biological Recent Development
11.8 Creative Biogene
11.8.1 Creative Biogene Company Details
11.8.2 Creative Biogene Business Overview
11.8.3 Creative Biogene Exogenous Circular RNA Synthesis Service Introduction
11.8.4 Creative Biogene Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.8.5 Creative Biogene Recent Development
11.9 GeneCopoeia
11.9.1 GeneCopoeia Company Details
11.9.2 GeneCopoeia Business Overview
11.9.3 GeneCopoeia Exogenous Circular RNA Synthesis Service Introduction
11.9.4 GeneCopoeia Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.9.5 GeneCopoeia Recent Development
11.10 CircNova
11.10.1 CircNova Company Details
11.10.2 CircNova Business Overview
11.10.3 CircNova Exogenous Circular RNA Synthesis Service Introduction
11.10.4 CircNova Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.10.5 CircNova Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs Exogenous Circular RNA Synthesis Service Introduction
11.11.4 Creative Biolabs Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.11.5 Creative Biolabs Recent Development
11.12 Bio-Synthesis
11.12.1 Bio-Synthesis Company Details
11.12.2 Bio-Synthesis Business Overview
11.12.3 Bio-Synthesis Exogenous Circular RNA Synthesis Service Introduction
11.12.4 Bio-Synthesis Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.12.5 Bio-Synthesis Recent Development
11.13 Hongene Biotech
11.13.1 Hongene Biotech Company Details
11.13.2 Hongene Biotech Business Overview
11.13.3 Hongene Biotech Exogenous Circular RNA Synthesis Service Introduction
11.13.4 Hongene Biotech Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025)
11.13.5 Hongene Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Exogenous Circular RNA Synthesis Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemical Synthesis Method
Table 3. Key Players of Ligase Method
Table 4. Key Players of Ribozyme Method
Table 5. Global Exogenous Circular RNA Synthesis Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Exogenous Circular RNA Synthesis Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Exogenous Circular RNA Synthesis Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Exogenous Circular RNA Synthesis Service Market Share by Region (2020-2025)
Table 9. Global Exogenous Circular RNA Synthesis Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Exogenous Circular RNA Synthesis Service Market Share by Region (2026-2031)
Table 11. Exogenous Circular RNA Synthesis Service Market Trends
Table 12. Exogenous Circular RNA Synthesis Service Market Drivers
Table 13. Exogenous Circular RNA Synthesis Service Market Challenges
Table 14. Exogenous Circular RNA Synthesis Service Market Restraints
Table 15. Global Exogenous Circular RNA Synthesis Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Exogenous Circular RNA Synthesis Service Market Share by Players (2020-2025)
Table 17. Global Top Exogenous Circular RNA Synthesis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exogenous Circular RNA Synthesis Service as of 2024)
Table 18. Ranking of Global Top Exogenous Circular RNA Synthesis Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Exogenous Circular RNA Synthesis Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Exogenous Circular RNA Synthesis Service, Headquarters and Area Served
Table 21. Global Key Players of Exogenous Circular RNA Synthesis Service, Product and Application
Table 22. Global Key Players of Exogenous Circular RNA Synthesis Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Exogenous Circular RNA Synthesis Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Type (2020-2025)
Table 26. Global Exogenous Circular RNA Synthesis Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Type (2026-2031)
Table 28. Global Exogenous Circular RNA Synthesis Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Application (2020-2025)
Table 30. Global Exogenous Circular RNA Synthesis Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Exogenous Circular RNA Synthesis Service Revenue Market Share by Application (2026-2031)
Table 32. North America Exogenous Circular RNA Synthesis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Exogenous Circular RNA Synthesis Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Exogenous Circular RNA Synthesis Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Exogenous Circular RNA Synthesis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Exogenous Circular RNA Synthesis Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Exogenous Circular RNA Synthesis Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Exogenous Circular RNA Synthesis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Exogenous Circular RNA Synthesis Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Exogenous Circular RNA Synthesis Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. GenScript Company Details
Table 48. GenScript Business Overview
Table 49. GenScript Exogenous Circular RNA Synthesis Service Product
Table 50. GenScript Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 51. GenScript Recent Development
Table 52. Guangzhou IGE Biotechnology Company Details
Table 53. Guangzhou IGE Biotechnology Business Overview
Table 54. Guangzhou IGE Biotechnology Exogenous Circular RNA Synthesis Service Product
Table 55. Guangzhou IGE Biotechnology Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 56. Guangzhou IGE Biotechnology Recent Development
Table 57. Geneseed Company Details
Table 58. Geneseed Business Overview
Table 59. Geneseed Exogenous Circular RNA Synthesis Service Product
Table 60. Geneseed Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 61. Geneseed Recent Development
Table 62. Azenta Life Sciences Company Details
Table 63. Azenta Life Sciences Business Overview
Table 64. Azenta Life Sciences Exogenous Circular RNA Synthesis Service Product
Table 65. Azenta Life Sciences Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 66. Azenta Life Sciences Recent Development
Table 67. Beyotime Company Details
Table 68. Beyotime Business Overview
Table 69. Beyotime Exogenous Circular RNA Synthesis Service Product
Table 70. Beyotime Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 71. Beyotime Recent Development
Table 72. VectorBuilder Company Details
Table 73. VectorBuilder Business Overview
Table 74. VectorBuilder Exogenous Circular RNA Synthesis Service Product
Table 75. VectorBuilder Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 76. VectorBuilder Recent Development
Table 77. Yaohai Biological Company Details
Table 78. Yaohai Biological Business Overview
Table 79. Yaohai Biological Exogenous Circular RNA Synthesis Service Product
Table 80. Yaohai Biological Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 81. Yaohai Biological Recent Development
Table 82. Creative Biogene Company Details
Table 83. Creative Biogene Business Overview
Table 84. Creative Biogene Exogenous Circular RNA Synthesis Service Product
Table 85. Creative Biogene Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 86. Creative Biogene Recent Development
Table 87. GeneCopoeia Company Details
Table 88. GeneCopoeia Business Overview
Table 89. GeneCopoeia Exogenous Circular RNA Synthesis Service Product
Table 90. GeneCopoeia Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 91. GeneCopoeia Recent Development
Table 92. CircNova Company Details
Table 93. CircNova Business Overview
Table 94. CircNova Exogenous Circular RNA Synthesis Service Product
Table 95. CircNova Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 96. CircNova Recent Development
Table 97. Creative Biolabs Company Details
Table 98. Creative Biolabs Business Overview
Table 99. Creative Biolabs Exogenous Circular RNA Synthesis Service Product
Table 100. Creative Biolabs Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 101. Creative Biolabs Recent Development
Table 102. Bio-Synthesis Company Details
Table 103. Bio-Synthesis Business Overview
Table 104. Bio-Synthesis Exogenous Circular RNA Synthesis Service Product
Table 105. Bio-Synthesis Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 106. Bio-Synthesis Recent Development
Table 107. Hongene Biotech Company Details
Table 108. Hongene Biotech Business Overview
Table 109. Hongene Biotech Exogenous Circular RNA Synthesis Service Product
Table 110. Hongene Biotech Revenue in Exogenous Circular RNA Synthesis Service Business (2020-2025) & (US$ Million)
Table 111. Hongene Biotech Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report


List of Figures
Figure 1. Exogenous Circular RNA Synthesis Service Picture
Figure 2. Global Exogenous Circular RNA Synthesis Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Exogenous Circular RNA Synthesis Service Market Share by Type: 2024 VS 2031
Figure 4. Chemical Synthesis Method Features
Figure 5. Ligase Method Features
Figure 6. Ribozyme Method Features
Figure 7. Global Exogenous Circular RNA Synthesis Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Exogenous Circular RNA Synthesis Service Market Share by Application: 2024 VS 2031
Figure 9. Drug Discovery Case Studies
Figure 10. Cell Therapy Case Studies
Figure 11. Vaccine R&D Case Studies
Figure 12. Disease Mechanism Case Studies
Figure 13. Exogenous Circular RNA Synthesis Service Report Years Considered
Figure 14. Global Exogenous Circular RNA Synthesis Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Exogenous Circular RNA Synthesis Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Exogenous Circular RNA Synthesis Service Market Share by Region: 2024 VS 2031
Figure 17. Global Exogenous Circular RNA Synthesis Service Market Share by Players in 2024
Figure 18. Global Exogenous Circular RNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Exogenous Circular RNA Synthesis Service Revenue in 2024
Figure 20. North America Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Exogenous Circular RNA Synthesis Service Market Share by Country (2020-2031)
Figure 22. United States Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Exogenous Circular RNA Synthesis Service Market Share by Country (2020-2031)
Figure 26. Germany Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Exogenous Circular RNA Synthesis Service Market Share by Region (2020-2031)
Figure 34. China Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Exogenous Circular RNA Synthesis Service Market Share by Country (2020-2031)
Figure 42. Mexico Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Exogenous Circular RNA Synthesis Service Market Share by Country (2020-2031)
Figure 46. Turkey Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Exogenous Circular RNA Synthesis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. GenScript Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 50. Guangzhou IGE Biotechnology Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 51. Geneseed Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 52. Azenta Life Sciences Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 53. Beyotime Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 54. VectorBuilder Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 55. Yaohai Biological Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 56. Creative Biogene Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 57. GeneCopoeia Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 58. CircNova Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 59. Creative Biolabs Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 60. Bio-Synthesis Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 61. Hongene Biotech Revenue Growth Rate in Exogenous Circular RNA Synthesis Service Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies